Sheet of BRUNOTTE François

Since 2017 : Prof Emeritus, University of Burgundy

1991-2017 : PU-PH in Biophysics and Nuclear Medicine nucléaire, University of Burgundy

1989-1990 : Researcher, Department of Biochemistry, University of Oxford

1990 : PhD, University of Nancy

1986 : MD, University of Nancy

PET/MRI in preclinical Imaging

Selected publications
Respective contribution of baseline clinical data, tumour metabolism and tumour blood-flow in predicting pCR after neoadjuvant chemotherapy in HER2 and Triple Negative breast cancer. Payan N, Presles B, Coutant C, Desmoulins I, Ladoire S, Beltjens F, Brunotte F, Vrigneaud JM, Cochet A. EJNMMI Res. 2024 Jul 4;14(1):60

A practical quality assurance procedure for data acquisitions in preclinical simultaneous PET/MR Systems. Courteau A, McGrath J, Walker PM, Presles B, Garipov R, Cochet A, Brunotte F, Vrigneaud JM. Mol Imaging Biol. 2023 Jun;25(3):450-463.

Critical analysis of the effect of various methodologies to compute breast cancer tumour blood flow-based texture features using first-pass 18F-FDG PET.

Payan N, Presles B, Truntzer C, Courcet E, Coutant C, Desmoulins I, Brunotte F, Vrigneaud JM, Cochet A.Phys Med. 2022 Nov;103:98-107.

[123I]MIBG is a better early marker of anthracycline cardiotoxicity than [18F]FDG: a preclinical SPECT/CT and simultaneous PET/MR study. Oudot A, Courteau A, Guillemin M, Vrigneaud JM, Walker PM, Brunotte F, Cochet A, Collin B. EJNMMI Res. 2021 Sep 20;11(1):92.

Performance evaluation and compatibility studies of a compact preclinical scanner for simultaneous PET/MR imaging at 7 tesla. Courteau A, McGrath J, Walker PM, Pegg R, Martin G, Garipov R, Doughty P, Cochet A, Brunotte F, Vrigneaud JM. IEEE Trans Med Imaging. 2021 Jan;40(1):205-217.

Participations at international masters :

-Innovative drugs

-Health-AI

-Medical Imaging and applications